Patents-Review.com
ClassID:

97215 ⎘

C07K16/38 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure

Recent Application in this class:
#1
20260116996
2026-04-30

COMPOSITIONS AND METHODS FOR TREATING SERPIN B13 DISORDERS

 #2
20250368752
2025-12-04

MONOCLONAL ANTIBODY AGAINST TFPI AND USE THEREOF

 #3
20250353927
2025-11-20

SERINE PROTEASE INHIBITOR KAZAL (SPIK) COMPOSITIONS AND METHODS

 #4
20250341529
2025-11-06

METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE

 #5
20250208146
2025-06-26

ALPHA-1 ANTITRYPSIN Z- AND M-SPECIFIC BINDING PROTEINS

 #6
20250154246
2025-05-15

NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

 #7
20250145732
2025-05-08

TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF

 #8
20240343828
2024-10-17

SPINK1 AS A TARGET FOR THERAPEUTIC INTERVENTION IN LUNG DISEASES

 #9
20240310377
2024-09-19

EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS

 #10
20240294610
2024-09-05

PEPTIDE FOR TREATING AGE-RELATED MACULAR DEGENERATION

 #11
20240166766
2024-05-23

Anti-A2AP antibodies and uses thereof

 #12
20240034810
2024-02-01

ANTI-A2AP ANTIBODIES AND USES THEREOF

 #13
20240025984
2024-01-25

CYTOSOLIC PROTEIN TARGETING DEUBIQUITINASES AND METHODS OF USE

 #14
20240010750
2024-01-11

NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF

 #15
20230416405
2023-12-28

Tissue factor pathway inhibitor antibodies and uses thereof

 #16
20230414855
2023-12-28

Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide in vivo

 #17
20230381392
2023-11-30

Blood processing apparatus and method for destroying cancer metastasis in vivo

 #18
20230357432
2023-11-09

PHARMACEUTICAL FORMULATION OF CONCIZUMAB AND METHOD OF PRODUCTION THEREOF

 #19
20230338489
2023-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

 #20
20230305023
2023-09-28

METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS

 #21
20230233711
2023-07-27

GENE THERAPY CONSTRUCTS AND METHODS OF USE

 #22
20230190637
2023-06-22

ANTIBODY AND PROTEIN FORMULATIONS

 #23
20230159659
2023-05-25

INHIBITION OF CYSTATINS FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS

 #24
20230099101
2023-03-30

SERINE PROTEASE INHIBITORS FOR SUPPRESSING OR PREVENTING ANAPHYLACTIC REACTION

 #25
20230042877
2023-02-09

NOVEL METHODS OF GENERATING ANTIBODIES

 #26
20230035617
2023-02-02

STABLE AQUEOUS ANTI-TFPI ANTIBODY FORMULATION

 #27
20230015181
2023-01-19

Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof

 #28
20220403047
2022-12-22

ANTIBODY SPECIFICALLY RECOGNIZING ITIH1, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR IMPROVING INSULIN RESISTANCE IN DISEASES ACCOMPANIED BY IMPAIRED GLUCOSE TOLERANCE

 #29
20220354936
2022-11-10

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

 #30
20220334135
2022-10-20

METHODS OF MEASURING COPPER CONCENTRATION IN BIOLOGICAL SAMPLES

 #31
20220325000
2022-10-13

MONOCLONAL ANTIBODY WHICH TARGETS TFPI

 #32
20220323587
2022-10-13

DISSOLVABLE FILMS AND METHODS OF THEIR USE

 #33
20220323559
2022-10-13

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

 #34
20220298261
2022-09-22

Serpinf2-Binding Molecules and Method of Use Thereof

 #35
20220280623
2022-09-08

Peptides and combination of peptides for use in immunotherapy against various cancers

 #36
20220280622
2022-09-08

Peptides and combination of peptides for use in immunotherapy against various cancers

 #37
20220273810
2022-09-01

ANTI-SERINE PROTEASE INHIBITOR KAZAL (SPIK) ANTIBODIES, IMMUNOCONJUGATES, AND METHODS OF USE

 #38
20220273783
2022-09-01

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

 #39
20220267468
2022-08-25

COMPOSITIONS AND METHODS FOR TREATING SERPIN B13 DISORDERS

 #40
20220265795
2022-08-25

Peptides and combination of peptides for use in immunotherapy against various cancers

 #41
20220265794
2022-08-25

Peptides and combination of peptides for use in immunotherapy against various cancers

 #42
20220265793
2022-08-25

Peptides and combination of peptides for use in immunotherapy against various cancers

 #43
20220257738
2022-08-18

Peptides and combination of peptides for use in immunotherapy against various cancers

 #44
20220257736
2022-08-18

Peptides and combination of peptides for use in immunotherapy against various cancers

 #45
20220249635
2022-08-11

Peptides and combination of peptides for use in immunotherapy against various cancers

 #46
20220041752
2022-02-10

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

 #47
20220026431
2022-01-27

Methods, arrays and uses thereof

 #48
20220025067
2022-01-27

Highly efficient anti-TFPI antibody composition

 #49
20210395391
2021-12-23

Dosage Regimen for TFPI Antagonists

 #50
20210388079
2021-12-16

NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

 #51
20210353728
2021-11-18

Peptides and combination of peptides for use in immunotherapy against various cancers

 #52
20210346481
2021-11-11

Peptides and combination of peptides for use in immunotherapy against various cancers

 #53
20210324107
2021-10-21

USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS

 #54
20210290745
2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

 #55
20210290744
2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

 #56
20210283231
2021-09-16

Peptides and combination of peptides for use in immunotherapy against various cancers

 #57
20210277145
2021-09-09

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INCREASING ENDOGENOUS PROTEIN LEVEL

 #58
20210275656
2021-09-09

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

 #59
20210260113
2021-08-26

DEVICES, METHODS, COMPOSITIONS AND SYSTEMS FOR THE TREATMENT OF AGING AND AGE-RELATED DISORDERS

 #60
20210253734
2021-08-19

Serine protease inhibitor kazal (SPIK) compositions and methods

 #61
20210188958
2021-06-24

B-cell epitope of cysteine protease inhibitor, hybridoma cell line, monoclonal antibody and uses thereof

 #62
20210162075
2021-06-03

Gene therapy constructs and methods of use

 #63
20210102168
2021-04-08

Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment

 #64
20210101998
2021-04-08

Tissue factor pathway inhibitor antibodies and uses thereof

 #65
20210087225
2021-03-25

Therapeutic protein compositions and methods

 #66
20210077381
2021-03-18

ANTIBODY AND PROTEIN FORMULATIONS

 #67
20200400683
2020-12-24

METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE

 #68
20200393464
2020-12-17

Evaluation, assays and treatment of pKal-mediated disorders

 #69
20200377573
2020-12-03

PEPTIDE FOR TREATING AGE-RELATED MACULAR DEGENERATION

 #70
20200354470
2020-11-12

Anti-presenilin antibody for use in the prevention and/or treatment of cancer

 #71
20200261490
2020-08-20

Pappalysin regulator

 #72
20200190214
2020-06-18

Tissue factor pathway inhibitor antibodies and uses thereof

 #73
20200173990
2020-06-04

Detection of citrullinated inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4)

 #74
20200155643
2020-05-21

Engineered anthrax protective antigen proteins for cancer therapy

 #75
20200140540
2020-05-07

T cell receptors and immune therapy using the same

 #76
20200116726
2020-04-16

PANCREATIC CANCER TARGETS AND USES THEREOF

 #77
20200093906
2020-03-26

Peptides and combination of peptides for use in immunotherapy against various cancers

 #78
20200031906
2020-01-30

Methods of treating cancer by administering inhibitory RNA molecules targeting protease serine 2 (PRSS2) expression

 #79
20200000902
2020-01-02

Peptides and combination of peptides for use in immunotherapy against various cancers

 #80
20190359729
2019-11-28

Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof

 #81
20190343968
2019-11-14

Gene therapy constructs and methods of use

 #82
20190298836
2019-10-03

DISSOLVABLE FILMS AND METHODS OF THEIR USE

 #83
20190269767
2019-09-05

Peptides and combination of peptides for use in immunotherapy against various cancers

 #84
20190262444
2019-08-29

Peptides and combination of peptides for use in immunotherapy against various cancers

 #85
20190256590
2019-08-22

T cell receptors and immune therapy using the same

 #86
20190211112
2019-07-11

Antibodies Against Tissue Factor Pathway Inhibitor

 #87
20190194353
2019-06-27

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

 #88
20190170754
2019-06-06

Method and reagent for detecting ovarian clear cell adenocarcinoma

 #89
20190100602
2019-04-04

ANTI-ANTITHROMBIN SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF

 #90
20190018020
2019-01-17

Methods for Early Diagnosis of Kidney Disease

 #91
20190015492
2019-01-17

Peptides and combination of peptides for use in immunotherapy against various cancers

 #92
20190002556
2019-01-03

T cell receptors and immune therapy using the same

 #93
20180360937
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

 #94
20180360936
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

 #95
20180355058
2018-12-13

Prophylaxis of thrombosis

 #96
20180334509
2018-11-22

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

 #97
20180282430
2018-10-04

ANTI-TFPI ANTIBODY VARIANTS WITH DIFFERENTIAL BINDING ACROSS PH RANGE FOR IMPROVED PHARMACOKINETICS

 #98
20180251570
2018-09-06

PROTEASE-REGULATED ANTIBODIES

 #99
20180244799
2018-08-30

Monoclonal antibodies against antithrombin beta

 #100
20180244759
2018-08-30

Methods of generating antibodies

 #101
20180214511
2018-08-02

Engineered anthrax protective antigen proteins for cancer therapy

 #102
20180208675
2018-07-26

Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor

 #103
20180195046
2018-07-12

Induced extended pluripotent stem cells, method of making and using

 #104
20180194857
2018-07-12

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

 #105
20180162953
2018-06-14

Assays for TIMP2 having improved performance in biological samples

 #106
20180155444
2018-06-07

Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof

 #107
20180105603
2018-04-19

Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A

 #108
20180055940
2018-03-01

ANTIBODY AND PROTEIN FORMULATIONS

 #109
20180030151
2018-02-01

Antibody binding to TFPI and composition comprising the same

 #110
20180028669
2018-02-01

ANTIBODY AND PROTEIN FORMULATIONS

 #111
20170342162
2017-11-30

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

 #112
20170322218
2017-11-09

METHOD AND REAGENT FOR DETECTING OVARIAN CLEAR CELL ADENOCARCINOMA

 #113
20170269101
2017-09-21

Methods and compositions for the detection and diagnosis of renal disease and periodontal disease

 #114
20170260289
2017-09-14

Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)

 #115
20170253664
2017-09-07

DUAL TARGETING OF TAFI AND PAI-1

 #116
20170253646
2017-09-07

Functional Peptide Analogs of PEDF

 #117
20170242035
2017-08-24

Diagnosis of sepsis and systemic inflammatory response syndrome

 #118
20170219591
2017-08-03

PANCREATIC CANCER TARGETS AND USES THEREOF

 #119
20170204140
2017-07-20

ANTAGONISTIC PEPTIDES

 #120
20170189513
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

 #121
20170189512
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

 #122
20170189511
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

 #123
20170189510
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

 #124
20170189506
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

 #125
20170189505
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

 #126
20170165338
2017-06-15

Peptides and combination of peptides for use in immunotherapy against various cancers

 #127
20170114147
2017-04-27

Antibodies Against Tissue Factor Pathway Inhibitor

 #128
20170107298
2017-04-20

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

 #129
20170073428
2017-03-16

Tissue factor pathway inhibitor antibodies and uses thereof

 #130
20160369008
2016-12-22

Anti-human PAI-1 antibody

 #131
20160347859
2016-12-01

Dual targeting of TAFI and PAI-1

 #132
20160304563
2016-10-20

Peptide inhibitors of BACE1

 #133
20160297893
2016-10-13

Assays for TIMP2 having improved performance in biological samples

 #134
20160200831
2016-07-14

Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereof

 #135
20160152729
2016-06-02

Antibodies recognizing the N-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity

 #136
20160067250
2016-03-10

Methods of treating cancer with a combination of selected MEK1/2 and AXL inhibitors

 #137
20160041173
2016-02-11

Methods and arrays for use in the same

 #138
20160039943
2016-02-11

Method of increasing plasmin activity through antiplasmin conversion

 #139
20160032012
2016-02-04

Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor

 #140
20160024222
2016-01-28

Monoclonal antibodies against antithrombin β

 #141
20160009818
2016-01-14

Anti-TFPI Antibody Variants with Differential Binding Across pH Range For Improved Pharmacokinetics

 #142
20150362492
2015-12-17

Assays for determining levels of plasma protease C1 inhibitor

 #143
20150361131
2015-12-17

HIGH TEMPERATURE DEAD END ANTIBODY FILTRATION

 #144
20150323526
2015-11-12

Immunochromatography devices, methods, and kits

 #145
20150168410
2015-06-18

BIOMARKERS FOR COLORECTAL CANCER DIAGNOSIS AND PREDICTION

 #146
20150079094
2015-03-19

Functional peptide analogs of PEDF

 #147
20150064169
2015-03-05

Thrombin/plasmin-regulated antibodies that bind TFPI

 #148
20150030591
2015-01-29

High concentration antibody and protein formulations

 #149
20150023920
2015-01-22

NOVEL COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CANCER METASTASIS

 #150
20150010536
2015-01-08

Humanized PAI-1 Antibodies and Uses Thereof

 #151
20140357566
2014-12-04

Identification and molecular characterisation of proteins, expressed in the salivary glands

 #152
20140308657
2014-10-16

SERINE PROTEASE INHIBITOR KAZAL ANTIBODIES

 #153
20140294832
2014-10-02

MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR (TFPI)

 #154
20140275493
2014-09-18

Anti-TFPI antibody variants with differential binding across PH range for improved pharmacokinetics

 #155
20140275491
2014-09-18

ANTIBODIES RECOGNIZING HUMAN TIMP1 PROTEIN

 #156
20140271661
2014-09-18

Monoclonal antibodies against antithrombin β

 #157
20140235473
2014-08-21

Diagnosis and/or Prognosis of Parkinson's Disease Dementia

 #158
20140234302
2014-08-21

Methods and compositions for reducing amyloid beta levels

 #159
20140228277
2014-08-14

Peptide inhibitors of BACE1

 #160
20140220034
2014-08-07

Serpinf2-binding molecules and method of use thereof

 #161
20140065159
2014-03-06

Antibody and protein formulations

 #162
20130302340
2013-11-14

HUMAN TIMP-1 ANTIBODIES

 #163
20130288279
2013-10-31

Specific A1AT monoclonal antibodies for detection of endometriosis

 #164
20130273052
2013-10-17

POLYPEPTIDES THAT BIND TO HUMAN COMPLEMENT COMPONENT C5

 #165
20130253173
2013-09-26

Antibodies that are capable of specifically binding tissue factor pathway inhibitor

 #166
20130251722
2013-09-26

Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitor

 #167
20130251721
2013-09-26

Antibodies against tissue factor pathway inhibitor

 #168
20130183698
2013-07-18

Immunochromatography devices, methods and kits

 #169
20130171153
2013-07-04

Proteins that bind PI16 and uses thereof

 #170
20130142804
2013-06-06

Antibodies that are capable of specifically binding tissue factor pathway inhibitor

 #171
20130129741
2013-05-23

Identification and molecular characterisation of proteins, expressed in the salivary glands

 #172
20130028907
2013-01-31

Stable antibody containing compositions

 #173
20130004971
2013-01-03

Cystatin C, β2 microglobulin, α1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy

 #174
20120329996
2012-12-27

Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

 #175
20120269817
2012-10-25

Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor

 #176
20120231013
2012-09-13

POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS

 #177
20120128677
2012-05-24

Pancreatic cancer targets and uses thereof

 #178
20120114652
2012-05-10

ANTI-PAI-1 ANTIBODIES AND METHODS OF USE THEREOF

 #179
20120108796
2012-05-03

Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)

 #180
20120082508
2012-04-05

Shutter Repair System

 #181
20120064100
2012-03-15

BIOMARKERS AND USES THEREOF

 #182
20110318356
2011-12-29

Antibodies against tissue factor pathway inhibitor

 #183
20110268745
2011-11-03

Antibodies against tissue factor pathway inhibitor (TFPI)

 #184
20110262429
2011-10-27

HUMAN TIMP-1 ANTIBODIES

 #185
20110236913
2011-09-29

Method for diagnosing immunoglobulin A nephropathy and TGBM nephropathy

 #186
20110236381
2011-09-29

INHIBITION OF INTER-ALPHA TRYPSIN INHIBITOR FOR THE TREATMENT OF AIRWAY DISEASE

 #187
20110212076
2011-09-01

Viral Therapeutic

 #188
20110206697
2011-08-25

SPINK1 TARGETED THERAPY

 #189
20100254979
2010-10-07

Humanized PAI-1 Antibodies and Uses Thereof

 #190
20100216119
2010-08-26

Diagnostic Methods for HIV Infection

 #191
20100215668
2010-08-26

Methods for the treatment or prevention of hemorrhagic conditions

 #192
20100183620
2010-07-22

COMPOSITIONS AND METHODS FOR REGULATING COLLAGEN AND SMOOTH MUSCLE ACTIN EXPRESSION BY SERPINE2

 #193
20100086536
2010-04-08

Method of increasing plasmin activity through antiplasmin conversion

 #194
20100040612
2010-02-18

Methods and compositions for reducing amyloid beta levels

 #195
20090318345
2009-12-24

MEANS AND METHODS FOR MODULATING STEM CELL MOBILIZATION

 #196
20090298754
2009-12-03

Hai-1 and hai-2 in cancer therapy

 #197
20090227518
2009-09-10

COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS

 #198
20090138977
2009-05-28

Pancreatic cancer targets and uses thereof

 #199
20090136500
2009-05-28

Humanized PAI-1 antibodies

 #200
20090053136
2009-02-26

Methods of Therapy and Diagnosis Using Immunotargeting of CD84Hy1-expressing Cells

 #201
20090035320
2009-02-05

Anti-PCI antibody for regulating liver regeneration/repair

 #202
20090023165
2009-01-22

Reagent and kit for early diagnosis of kidney disease

 #203
20090017037
2009-01-15

Human TIMP-1 antibodies

 #204
20080219970
2008-09-11

Identification and molecular characterisation of proteins, expressed in the salivary glands

 #205
20080166354
2008-07-10

SUPPRESSION OF INHIBITORS

 #206
20080021201
2008-01-24

Protease inhibitor conjugates and antibodies useful in immunoassay

 #207
20070160614
2007-07-12

Human TIMP-1 antibodies

 #208
20070155959
2007-07-05

Protease inhibitor conjugates and antibodies useful in immunoassay

 #209
20070149565
2007-06-28

Nelfinavir conjugates and antibodies useful in immunoassay

 #210
20070148708
2007-06-28

Protease inhibitor conjugates and antibodies useful in immunoassay

 #211
20070142641
2007-06-21

Atazanavir conjugates and antibodies useful in immunoassay

 #212
20070141643
2007-06-21

Protease inhibitor conjugates and antibodies useful in immunoassay

 #213
20060264618
2006-11-23

PROTEASE INHIBITOR CONJUGATES AND ANTIBODIES USEFUL IN IMMUNOASSAY

 #214
20060233776
2006-10-19

C1-inh as a drug for treating viruses pathogenic to humans

 #215
20060211107
2006-09-21

Saquinavir conjugates and antibodies useful in immunoassay

 #216
20060167230
2006-07-27

Anti-pci neutralizing antibody

 #217
20060121591
2006-06-08

Mutant proteinase-inhibitors and uses thereof

 #218
20060104977
2006-05-18

Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells

 #219
20060068480
2006-03-30

Polypeptides and polypeptide analogues

 #220
20060008900
2006-01-12

Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene

 #221
20050239215
2005-10-27

Isolated Polynucleotide encoding modified fab' antibody, expression vector, and transformed host cell

 #222
20050196390
2005-09-08

Methods for detecting metalloproteinase inhibitors

 #223
20050152895
2005-07-14

Prevention of adhesions

 #224
20050148596
2005-07-07

Indinavir derivatives useful in immunoassay

 #225
20050142137
2005-06-30

Antibodies against secretoryleukocyte protease inhibitor

 #226
20050095685
2005-05-05

Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin

 #227
20050064517
2005-03-24

Methods of inhibiting transmission of a costimulatory signal of lymphocytes